back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-04-09 15:24 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Bejar, Rafael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-171,939 vol |
5,925 | |
| Filed 2025-04-09 15:23 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Bejar, Rafael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-7,089 vol |
244 | |
| Filed 2024-02-08 10:04 Tx date 2024-02-05 |
$APS
Aptose Biosciences Inc. |
Bejar, Rafael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,000 vol |
177,864 | |
| Filed 2023-08-17 20:26 Tx date 2023-05-24 |
$APS
Aptose Biosciences Inc. |
Bejar, Rafael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-2,000,136 vol |
142,864 | |
| Filed 2023-08-17 20:25 Tx date 2023-05-24 |
$APS
Aptose Biosciences Inc. |
Bejar, Rafael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-102,667 vol |
7,333 | |
| Filed 2023-01-24 15:36 Tx date 2023-01-19 |
$APS
Aptose Biosciences Inc. |
Bejar, Rafael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+100,000 vol |
110,000 | |
| Filed 2023-01-24 15:35 Tx date 2023-01-19 |
$APS
Aptose Biosciences Inc. |
Bejar, Rafael
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-100,000 vol |
0 | |
| Filed 2023-01-24 15:34 Tx date 2023-01-19 |
$APS
Aptose Biosciences Inc. |
Bejar, Rafael
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+100,000 vol |
100,000 | |
| Filed 2023-01-24 15:34 Tx date 2020-01-01 |
$APS
Aptose Biosciences Inc. |
Bejar, Rafael
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-24 15:33 Tx date 2023-01-19 |
$APS
Aptose Biosciences Inc. |
Bejar, Rafael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
2,143,000 | |
| Filed 2022-01-20 18:46 Tx date 2022-01-18 |
$APS
Aptose Biosciences Inc. |
Bejar, Rafael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+600,000 vol |
1,943,000 | |
| Filed 2021-11-22 10:30 Tx date 2021-11-19 |
$APS
Aptose Biosciences Inc. |
Bejar, Rafael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,600
+10,000 vol $2.56 each |
10,000 | |
| Filed 2021-11-22 10:27 Tx date 2020-01-01 |
$APS
Aptose Biosciences Inc. |
Bejar, Rafael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-08-23 17:56 Tx date 2021-08-19 |
$APS
Aptose Biosciences Inc. |
Bejar, Rafael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
1,343,000 | |
| Filed 2021-01-06 19:49 Tx date 2021-01-04 |
$APS
Aptose Biosciences Inc. |
Bejar, Rafael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+343,000 vol |
943,000 | |
| Filed 2020-02-03 11:05 Tx date 2020-01-31 |
$APS
Aptose Biosciences Inc. |
Bejar, Rafael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
600,000 | |
| Filed 2020-01-03 17:11 Tx date 2020-01-01 |
$APS
Aptose Biosciences Inc. |
Bejar, Rafael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
400,000 | |
| Filed 2020-01-03 17:06 Tx date 2020-01-01 |
$APS
Aptose Biosciences Inc. |
Bejar, Rafael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|